Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. 2009

Matteo Ricchi, and Maria Rosaria Odoardi, and Lucia Carulli, and Claudia Anzivino, and Stefano Ballestri, and Adriano Pinetti, and Luca Isaia Fantoni, and Fabio Marra, and Marco Bertolotti, and Sebastiano Banni, and Amedeo Lonardo, and Nicola Carulli, and Paola Loria
Dipartimento Integrato di Medicina Interna, Endocrinologia, Metabolismo & Geriatria, UniversitĆ  degli Studi di Modena e Reggio Emilia, Modena, Italy.

OBJECTIVE Studies have shown monounsaturated oleic acid to be less toxic than palmitic acid and to prevent/attenuate palmitic acid hepatocites toxicity in steatosis models in vitro. However, to what degree these effects are mediated by steatosis extent is unknown. METHODS We evaluated whether steatosis per se is associated with hepatocytes apoptosis and determined the role of oleic and palmitic acid, the most abundant fatty acids in western diets, on triglyceride accumulation and apoptosis in an in vitro model of steatosis induced in three hepatocytic cell lines (HepG2, HuH7, WRL68). The impact of incubation for 24 h with oleic (0.66 and 1.32 mM) and palmitic acid (0.33 and 0.66 mM), alone or combined (molar ratio 2 : 1) on steatosis, apoptosis, and insulin signalling, was evaluated. RESULTS Concurrent with PPARgamma and SREBP-1 gene activation, steatosis extent was larger when cells were treated with oleic than with palmitic acid; the latter fatty acid was associated with increased PPARalpha expression. Cell apoptosis was inversely proportional to steatosis deposition. Moreover, palmitic, but not oleic acid, impaired insulin signalling. Despite the higher amount of fat resulting from incubation of the two fatty acids combined, the apoptosis rate and impaired insulin signalling were lower than in cells treated with palmitic acid alone, indicating a protective effect of oleic acid. CONCLUSIONS Oleic acid is more steatogenic but less apoptotic than palmitic acid in hepatocityc cell cultures. These data may provide a biological basis for clinical findings on dietary patterns and pathogenetic models of nonalcoholic fatty liver disease.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014280 Triglycerides An ester formed from GLYCEROL and three fatty acid groups. Triacylglycerol,Triacylglycerols,Triglyceride
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis

Related Publications

Matteo Ricchi, and Maria Rosaria Odoardi, and Lucia Carulli, and Claudia Anzivino, and Stefano Ballestri, and Adriano Pinetti, and Luca Isaia Fantoni, and Fabio Marra, and Marco Bertolotti, and Sebastiano Banni, and Amedeo Lonardo, and Nicola Carulli, and Paola Loria
July 2022, Biochemical and biophysical research communications,
Matteo Ricchi, and Maria Rosaria Odoardi, and Lucia Carulli, and Claudia Anzivino, and Stefano Ballestri, and Adriano Pinetti, and Luca Isaia Fantoni, and Fabio Marra, and Marco Bertolotti, and Sebastiano Banni, and Amedeo Lonardo, and Nicola Carulli, and Paola Loria
June 1996, The Biochemical journal,
Matteo Ricchi, and Maria Rosaria Odoardi, and Lucia Carulli, and Claudia Anzivino, and Stefano Ballestri, and Adriano Pinetti, and Luca Isaia Fantoni, and Fabio Marra, and Marco Bertolotti, and Sebastiano Banni, and Amedeo Lonardo, and Nicola Carulli, and Paola Loria
September 2023, Molecules (Basel, Switzerland),
Matteo Ricchi, and Maria Rosaria Odoardi, and Lucia Carulli, and Claudia Anzivino, and Stefano Ballestri, and Adriano Pinetti, and Luca Isaia Fantoni, and Fabio Marra, and Marco Bertolotti, and Sebastiano Banni, and Amedeo Lonardo, and Nicola Carulli, and Paola Loria
August 2021, Archives of physiology and biochemistry,
Matteo Ricchi, and Maria Rosaria Odoardi, and Lucia Carulli, and Claudia Anzivino, and Stefano Ballestri, and Adriano Pinetti, and Luca Isaia Fantoni, and Fabio Marra, and Marco Bertolotti, and Sebastiano Banni, and Amedeo Lonardo, and Nicola Carulli, and Paola Loria
September 1990, Lipids,
Matteo Ricchi, and Maria Rosaria Odoardi, and Lucia Carulli, and Claudia Anzivino, and Stefano Ballestri, and Adriano Pinetti, and Luca Isaia Fantoni, and Fabio Marra, and Marco Bertolotti, and Sebastiano Banni, and Amedeo Lonardo, and Nicola Carulli, and Paola Loria
April 2011, Molecular and cellular biochemistry,
Matteo Ricchi, and Maria Rosaria Odoardi, and Lucia Carulli, and Claudia Anzivino, and Stefano Ballestri, and Adriano Pinetti, and Luca Isaia Fantoni, and Fabio Marra, and Marco Bertolotti, and Sebastiano Banni, and Amedeo Lonardo, and Nicola Carulli, and Paola Loria
September 2017, Lipids,
Matteo Ricchi, and Maria Rosaria Odoardi, and Lucia Carulli, and Claudia Anzivino, and Stefano Ballestri, and Adriano Pinetti, and Luca Isaia Fantoni, and Fabio Marra, and Marco Bertolotti, and Sebastiano Banni, and Amedeo Lonardo, and Nicola Carulli, and Paola Loria
January 2017, Molecular and cellular endocrinology,
Matteo Ricchi, and Maria Rosaria Odoardi, and Lucia Carulli, and Claudia Anzivino, and Stefano Ballestri, and Adriano Pinetti, and Luca Isaia Fantoni, and Fabio Marra, and Marco Bertolotti, and Sebastiano Banni, and Amedeo Lonardo, and Nicola Carulli, and Paola Loria
May 2019, Experimental gerontology,
Matteo Ricchi, and Maria Rosaria Odoardi, and Lucia Carulli, and Claudia Anzivino, and Stefano Ballestri, and Adriano Pinetti, and Luca Isaia Fantoni, and Fabio Marra, and Marco Bertolotti, and Sebastiano Banni, and Amedeo Lonardo, and Nicola Carulli, and Paola Loria
January 2015, Physiological research,
Copied contents to your clipboard!